Etiology, Stigmata & Clinical Differentiation
| Question | Answer |
|---|---|
| 1. What are the common etiologies of Chronic Liver Disease in Indian children based on age? | - Infancy ($<1\text{ year}$): Biliary atresia, progressive familial intrahepatic cholestasis (PFIC), alpha-1 antitrypsin deficiency, galactosemia, tyrosinemia, neonatal hepatitis. - Young Child ($1-5\text{ years}$): Autoimmune hepatitis, Indian Childhood Cirrhosis (copper toxicity), Glycogen storage disease (Type IV), Gaucher disease, PFIC. - Older Child ($>5\text{ years}$): Wilson Disease (most common), Autoimmune Hepatitis (Type 1 & 2), Chronic Viral Hepatitis B and C, Non-Alcoholic Steatohepatitis (NASH), Alpha-1 antitrypsin deficiency. |
| 2. Enumerate the peripheral stigmata of Chronic Liver Disease and their pathophysiology. | 1) Spider Angiomas / Nevi: Central pulsating arteriole with radiating blanching capillaries (face, neck, upper chest) due to impaired hepatic metabolism of estrogens causing hyperestrogenism. 2) Palmar Erythema: Symmetrical redness of thenar and hypothenar eminences (hyperdynamic circulation and hyperestrogenism). 3) Leuconychia (Muehrcke's lines / Terry's nails): Opaque white nail beds due to chronic hypoalbuminemia. 4) Clubbing: Loss of Lovibond angle due to pulmonary vasodilatation and circulating vasodilators. 5) Bilateral Parotid Enlargement & Temporal Wasting: Malnutrition and chronic alcoholic/metabolic cirrhosis. 6) Caput Medusae: Recanalized umbilical vein radiating from the umbilicus due to severe portal hypertension. |
| 3. How do you clinically differentiate Extrahepatic Portal Venous Obstruction (EHPVO) from Cirrhotic Portal Hypertension? | |
| 4. What is the anatomical landmark and flow direction in abdominal wall collaterals? | - Portal Hypertension Collaterals (Caput Medusae): Blood flows centrifugally AWAY from the umbilicus (upward above the umbilicus toward the superior vena cava; downward below the umbilicus toward the inferior vena cava). - Inferior Vena Cava (IVC) Obstruction Collaterals: Blood flows uniformly UPWARD from the lower abdomen toward the thorax across all collateral vessels. |
Wilson Disease: Pathogenesis, Scoring & Management
| Question | Answer |
|---|---|
| 5. What is the basic genetic and molecular defect in Wilson Disease? | Autosomal recessive mutation in the ATP7B gene on chromosome $13q14.3$, encoding a copper-transporting P-type ATPase. This defect impairs two fundamental processes in hepatocytes: 1) Failure to excrete copper into bile (the primary physiological excretory pathway). 2) Failure to incorporate copper into apoceruloplasmin to form mature ceruloplasmin. Toxic unbound free copper accumulates first in the cytoplasm of hepatocytes (causing hepatitis and cirrhosis), spills into circulation, and deposits in the basal ganglia (lenticular nuclei), Descemet membrane of the cornea (KF rings), kidneys, and erythrocytes (inducing acute Coombs-negative hemolytic anemia). |
| 6. Describe the Kayser-Fleischer (KF) ring and its clinical significance. | The KF ring is a golden-brown or greenish granular pigmentation located in Descemet's membrane at the limbus of the cornea, resulting from copper deposition. - Best visualized by Slit-Lamp Biomicroscopy. - It begins at the superior pole (12 o'clock), then the inferior pole (6 o'clock), and finally becomes circumferential. - Present in $>95-98\%$ of patients with neurological Wilson disease, but in only $50-60\%$ of patients with purely hepatic Wilson disease. - Clinical Significance: Reversible with effective decoppering therapy. |
| 7. Explain the Leipzig Diagnostic Criteria for Wilson Disease. | A composite scoring system based on 7 clinical and biochemical parameters: - KF Rings: Present (2 points), Absent (0). - Neurological Symptoms: Severe (2), Mild (1), Absent (0). - Serum Ceruloplasmin: $<10\text{ mg/dL}$ (2), $10-20\text{ mg/dL}$ (1), Normal $>20$ (0). - Coombs-Negative Hemolytic Anemia: Present (1), Absent (0). - Liver Copper (if biopsy performed): $>250\text{ mcg/g}$ dry weight (2), $50-250$ (1), Normal $<50$ (-1). - Urinary Copper (24-hr): $>2 \times\text{ ULN}$ ($>80\text{ mcg/24h}$) (2), $1-2 \times\text{ ULN}$ (1), Normal (0). - Mutation Analysis: Both chromosomes detected (4), One chromosome (1), None (0). Interpretation: Score $\ge 4$ establishes a DEFINITE diagnosis of Wilson Disease; Score 3 = Probable; Score $\le 2$ = Unlikely. |
| 8. Detail the pharmacological management of Wilson Disease. | 1) Chelating Phase (Decoppering): - D-Penicillamine: $20\text{ mg/kg/day}$ divided bid (taken 1 hr before meals). Co-prescribe Pyridoxine (Vit B6) $25-50\text{ mg/day}$. Must start at low dose ($5-10\text{ mg/kg}$) and titrate upward to prevent paradoxical neurological deterioration. - Trientine (Triethylene tetramine): $20\text{ mg/kg/day}$ divided bid; preferred first-line for neurologic disease or if penicillamine adverse effects occur (proteinuria, rash, cytopenias). 2) Maintenance Phase / Intestinal Blockade: - Oral Zinc (Zinc Acetate / Gluconate): $50\text{ mg}$ elemental zinc tid for children $>5$ years. Induces enterocyte metallothionein, which binds luminal copper and sloughs off with feces. 3) Dietary Copper Restriction: Avoid organ meats, shellfish, mushrooms, nuts, and chocolate. |
| 9. VIVA TRAP: What is the "Revised King's College Wilson Index" and when is Liver Transplantation mandatory? | In acute liver failure due to Wilson disease (often presenting with acute Coombs-negative intravascular hemolysis, high bilirubin, low ALP, and AST:ALT $>2.0$), medical chelation is uniformly fatal. The Revised King's Wilson Index calculates a prognostic score based on: Bilirubin, INR, AST, White Blood Cell count, and Albumin. VIVA TRAP: A Score $\ge 11$ points predicts 100% mortality without transplantation. Immediate referral for Emergency Living-Donor Liver Transplantation (LDLT) is mandatory! |
Portal Hypertension & Ascites Management
| Question | Answer |
|---|---|
| 10. How is Acute Variceal Bleeding managed in a child? | 1) Resuscitation: Secure airway, high-flow oxygen, two large-bore IV cannulae. Transfuse PRBC to maintain target hemoglobin around $8.0\text{ g/dL}$ (avoid over-transfusion, which raises portal pressure and triggers rebleeding!). 2) Vasoactive Pharmacotherapy: Immediate IV Octreotide (somatostatin analogue: bolus $1\text{ mcg/kg}$, followed by infusion $1-2\text{ mcg/kg/hour}$) or Terlipressin to induce splanchnic vasoconstriction and decrease portal inflow. 3) Endoscopic Intervention: Emergency Upper GI Endoscopy within 12–24 hours: Endoscopic Variceal Ligation (EVL / Banding) is the treatment of choice. Sclerotherapy if banding impossible. 4) Prophylactic Antibiotics: IV Ceftriaxone for 5 days (prevents SBP and rebleeding). 5) Secondary Prophylaxis: Elective EVL every 2–4 weeks until varices are obliterated, plus oral Propranolol ($0.5-2\text{ mg/kg/day}$). |
| 11. What is the protocol for Diuretic Management of Ascites in Cirrhosis? | - Dietary Sodium: Strict salt restriction to $<2\text{ g/day}$ ($<1-2\text{ mEq/kg/day}$). - Combination Diuretic Therapy: Combine Oral Spironolactone ($2-4\text{ mg/kg/day}$) and Oral Furosemide ($1-2\text{ mg/kg/day}$), maintaining a strict 100 mg : 40 mg ratio. Rationale: Spironolactone tackles hyperaldosteronism while furosemide blocks the loop of Henle; the 100:40 ratio preserves serum potassium neutrality. - Monitor daily weight (target weight loss $0.5\text{ kg/day}$); halt if encephalopathy, hyponatremia ($<125$), or azotemia develops. |
| 12. Counter-Question Chain: "How do you diagnose Spontaneous Bacterial Peritonitis (SBP) on paracentesis?" | 1) Diagnostic Paracentesis: Indicated immediately in any cirrhotic child with fever, abdominal pain, worsening ascites, or unexplained encephalopathy. 2) Diagnostic Criteria: Ascitic fluid Absolute Neutrophil Count (ANC) $\ge 250\text{ cells/mm}^3$ ($0.25 \times 10^9/\text{L}$) calculated as: $\text{Ascitic Fluid WBC} \times \%\text{ Polymorphs}$. 3) Treatment: Immediate IV Ceftriaxone / Cefotaxime ($100\text{ mg/kg/day}$) + IV 20% Albumin ($1.5\text{ g/kg}$ on day 1 and $1.0\text{ g/kg}$ on day 3 to prevent hepatorenal syndrome). |